Page last updated: 2024-08-16

resveratrol and ursodeoxycholic acid

resveratrol has been researched along with ursodeoxycholic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Abdel-Latif, HA; Ali, MH; Messiha, BA1
Chen, Z; Hu, L; Lu, M; Shen, Z1
He, P; Lei, JH; Wang, CX; Yuan, WG; Zhang, CY1
Bai, Y; Huang, J; Huang, W; Lu, X; Shu, P; Wen, F1
Lei, L; Li, Z; Ling, L; Liu, Y; Shao, Y; Xiong, Z1
Feng, F; Huang, X; Lei, L; Shao, Y1

Reviews

1 review(s) available for resveratrol and ursodeoxycholic acid

ArticleYear
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
    World journal of gastroenterology, 2016, Dec-28, Volume: 22, Issue:48

    Topics: Acetyl-CoA C-Acetyltransferase; Animals; CD4-Positive T-Lymphocytes; Disease Progression; Fatty Liver, Alcoholic; Hepatic Stellate Cells; Humans; Interleukins; Intracellular Signaling Peptides and Proteins; LIM Domain Proteins; Liver Cirrhosis; Macrophages; MicroRNAs; Molecular Targeted Therapy; Non-alcoholic Fatty Liver Disease; Resveratrol; Schistosomiasis; Signal Transduction; Stilbenes; T-Lymphocytes, Regulatory; Triterpenes; Ursodeoxycholic Acid; Ursolic Acid; Virus Diseases

2016

Other Studies

5 other study(ies) available for resveratrol and ursodeoxycholic acid

ArticleYear
Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.
    Pharmaceutical biology, 2016, Volume: 54, Issue:7

    Topics: Acetylcysteine; Animals; Antioxidants; Biomarkers; Choline Deficiency; Cytoprotection; Disease Models, Animal; Hypolipidemic Agents; Lipids; Liver; Male; Methionine; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats, Wistar; Resveratrol; Stilbenes; Ursodeoxycholic Acid

2016
Resveratrol reduces matrix metalloproteinases and alleviates intrahepatic cholestasis of pregnancy in rats.
    Canadian journal of physiology and pharmacology, 2016, Volume: 94, Issue:4

    Topics: Animals; Cholestasis, Intrahepatic; Female; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Pregnancy; Pregnancy Complications; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Ursodeoxycholic Acid

2016
Identification of hub genes and discovery of promising compounds in gastric cancer based on bioinformatics analysis.
    Biomarkers in medicine, 2020, Volume: 14, Issue:12

    Topics: Amiodarone; Cell Cycle Proteins; Clomipramine; Collagen Type I; Databases, Genetic; Datasets as Topic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Ki-67 Antigen; Levallorphan; Microtubule-Associated Proteins; Neoplasm Proteins; Osteopontin; Piroxicam; Polo-Like Kinase 1; Procaine; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Resveratrol; Small Molecule Libraries; Stomach Neoplasms; Ursodeoxycholic Acid; Vorinostat

2020
Resveratrol modulates the gut microbiota of cholestasis in pregnant rats.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2022, Volume: 73, Issue:2

    Topics: Alanine; Alanine Transaminase; Animals; Aspartic Acid; Bile Acids and Salts; Cholestasis; Cholestasis, Intrahepatic; Dysbiosis; Ethinyl Estradiol; Female; Gastrointestinal Microbiome; Glutamates; Pregnancy; Pregnancy Complications; Rats; Resveratrol; RNA, Ribosomal, 16S; Ursodeoxycholic Acid

2022
Distribution of endotoxin in maternal and fetal body with intrahepatic cholestasis of pregnancy and its association with adverse fetal outcome.
    BMC pregnancy and childbirth, 2022, Dec-08, Volume: 22, Issue:1

    Topics: Animals; Endotoxins; Family; Female; Humans; Mice; Resveratrol; Ursodeoxycholic Acid

2022